Matches in SemOpenAlex for { <https://semopenalex.org/work/W2328747114> ?p ?o ?g. }
- W2328747114 endingPage "1933" @default.
- W2328747114 startingPage "1929" @default.
- W2328747114 abstract "To analyze longterm progression to rheumatoid arthritis (RA) and the predictive value of anticitrullinated peptide/protein antibodies (ACPA) in palindromic rheumatism (PR).We selected all patients in our clinic with PR who had at least 1 ACPA measurement. We included only patients with pure PR, defined as no evidence of associated rheumatic disease at the first serum ACPA measurement. Clinical characteristics, serum ACPA levels, duration of PR until serum ACPA measurement, and total followup time were recorded. The outcome variable was the definitive diagnosis of RA. The prognostic value of ACPA status in pure PR for a definite diagnosis of RA was analyzed by different statistical methods.Seventy-one patients (54 women/17 men) with a PR diagnosis were included. Serum ACPA were positive in 52.1%. After a mean followup of 7.6 ± 4.7 years since the first ACPA measurement, 24 patients (33.8%) progressed to chronic disease: 22% RA, 5.6% systemic lupus erythematosus, and 5.6% other diseases. The positive likelihood ratio of ACPA status for RA was 1.45, and the area under the receiver-operating characteristic curve of ACPA titers was 0.60 (95% CI 0.45-0.75). Progression to RA was more frequently seen in ACPA-positive than in ACPA-negative patients (29.7% vs 14.7%), but the difference was not significant (hazard ratio 2.46, 95% CI 0.77-7.86). Mean ACPA levels of patients with pure PR did not differ significantly from those of patients who progressed to RA.ACPA are frequently found in the sera of patients with PR, and a significant proportion of these patients do not progress to RA in the long term." @default.
- W2328747114 created "2016-06-24" @default.
- W2328747114 creator A5002102037 @default.
- W2328747114 creator A5005788294 @default.
- W2328747114 creator A5007766318 @default.
- W2328747114 creator A5008659651 @default.
- W2328747114 creator A5008861132 @default.
- W2328747114 creator A5016122411 @default.
- W2328747114 creator A5031598739 @default.
- W2328747114 creator A5034945058 @default.
- W2328747114 creator A5041596944 @default.
- W2328747114 date "2012-08-01" @default.
- W2328747114 modified "2023-10-16" @default.
- W2328747114 title "Palindromic Rheumatism with Positive Anticitrullinated Peptide/Protein Antibodies Is Not Synonymous with Rheumatoid Arthritis. A Longterm Followup Study" @default.
- W2328747114 cites W2013990419 @default.
- W2328747114 cites W2020352110 @default.
- W2328747114 cites W2032221360 @default.
- W2328747114 cites W2069744023 @default.
- W2328747114 cites W2106677069 @default.
- W2328747114 cites W2117688080 @default.
- W2328747114 cites W2133026816 @default.
- W2328747114 cites W2140191073 @default.
- W2328747114 cites W2149266658 @default.
- W2328747114 cites W2162972580 @default.
- W2328747114 cites W2166453502 @default.
- W2328747114 doi "https://doi.org/10.3899/jrheum.120568" @default.
- W2328747114 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22859345" @default.
- W2328747114 hasPublicationYear "2012" @default.
- W2328747114 type Work @default.
- W2328747114 sameAs 2328747114 @default.
- W2328747114 citedByCount "29" @default.
- W2328747114 countsByYear W23287471142012 @default.
- W2328747114 countsByYear W23287471142013 @default.
- W2328747114 countsByYear W23287471142014 @default.
- W2328747114 countsByYear W23287471142015 @default.
- W2328747114 countsByYear W23287471142017 @default.
- W2328747114 countsByYear W23287471142018 @default.
- W2328747114 countsByYear W23287471142019 @default.
- W2328747114 countsByYear W23287471142020 @default.
- W2328747114 countsByYear W23287471142021 @default.
- W2328747114 countsByYear W23287471142022 @default.
- W2328747114 crossrefType "journal-article" @default.
- W2328747114 hasAuthorship W2328747114A5002102037 @default.
- W2328747114 hasAuthorship W2328747114A5005788294 @default.
- W2328747114 hasAuthorship W2328747114A5007766318 @default.
- W2328747114 hasAuthorship W2328747114A5008659651 @default.
- W2328747114 hasAuthorship W2328747114A5008861132 @default.
- W2328747114 hasAuthorship W2328747114A5016122411 @default.
- W2328747114 hasAuthorship W2328747114A5031598739 @default.
- W2328747114 hasAuthorship W2328747114A5034945058 @default.
- W2328747114 hasAuthorship W2328747114A5041596944 @default.
- W2328747114 hasConcept C126322002 @default.
- W2328747114 hasConcept C159654299 @default.
- W2328747114 hasConcept C163764329 @default.
- W2328747114 hasConcept C198451711 @default.
- W2328747114 hasConcept C203014093 @default.
- W2328747114 hasConcept C207103383 @default.
- W2328747114 hasConcept C2776232647 @default.
- W2328747114 hasConcept C2776670291 @default.
- W2328747114 hasConcept C2777077863 @default.
- W2328747114 hasConcept C2777489490 @default.
- W2328747114 hasConcept C2777575956 @default.
- W2328747114 hasConcept C2779075594 @default.
- W2328747114 hasConcept C2779134260 @default.
- W2328747114 hasConcept C32611913 @default.
- W2328747114 hasConcept C44249647 @default.
- W2328747114 hasConcept C58471807 @default.
- W2328747114 hasConcept C71924100 @default.
- W2328747114 hasConcept C90924648 @default.
- W2328747114 hasConceptScore W2328747114C126322002 @default.
- W2328747114 hasConceptScore W2328747114C159654299 @default.
- W2328747114 hasConceptScore W2328747114C163764329 @default.
- W2328747114 hasConceptScore W2328747114C198451711 @default.
- W2328747114 hasConceptScore W2328747114C203014093 @default.
- W2328747114 hasConceptScore W2328747114C207103383 @default.
- W2328747114 hasConceptScore W2328747114C2776232647 @default.
- W2328747114 hasConceptScore W2328747114C2776670291 @default.
- W2328747114 hasConceptScore W2328747114C2777077863 @default.
- W2328747114 hasConceptScore W2328747114C2777489490 @default.
- W2328747114 hasConceptScore W2328747114C2777575956 @default.
- W2328747114 hasConceptScore W2328747114C2779075594 @default.
- W2328747114 hasConceptScore W2328747114C2779134260 @default.
- W2328747114 hasConceptScore W2328747114C32611913 @default.
- W2328747114 hasConceptScore W2328747114C44249647 @default.
- W2328747114 hasConceptScore W2328747114C58471807 @default.
- W2328747114 hasConceptScore W2328747114C71924100 @default.
- W2328747114 hasConceptScore W2328747114C90924648 @default.
- W2328747114 hasIssue "10" @default.
- W2328747114 hasLocation W23287471141 @default.
- W2328747114 hasLocation W23287471142 @default.
- W2328747114 hasOpenAccess W2328747114 @default.
- W2328747114 hasPrimaryLocation W23287471141 @default.
- W2328747114 hasRelatedWork W182203678 @default.
- W2328747114 hasRelatedWork W1981471379 @default.
- W2328747114 hasRelatedWork W1999301958 @default.
- W2328747114 hasRelatedWork W2282015971 @default.
- W2328747114 hasRelatedWork W2310244359 @default.
- W2328747114 hasRelatedWork W2342916283 @default.